Cargando…

Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease

The presence of hallucinations and delusions in patients with neurodegenerative disease correlates negatively with function, cognition, quality of life, and survival. When these patients still have insight, the treatment of mild hallucinations may reduce the risk of progression to more severe sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Chepke, Craig, Shaughnessy, Lynn W, Brunton, Stephen, Farmer, Jill G, Rosenzweig, Andrew S, Grossberg, George T, Wright, Wendy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711560/
https://www.ncbi.nlm.nih.gov/pubmed/34992442
http://dx.doi.org/10.2147/IJGM.S335739
_version_ 1784623395040657408
author Chepke, Craig
Shaughnessy, Lynn W
Brunton, Stephen
Farmer, Jill G
Rosenzweig, Andrew S
Grossberg, George T
Wright, Wendy L
author_facet Chepke, Craig
Shaughnessy, Lynn W
Brunton, Stephen
Farmer, Jill G
Rosenzweig, Andrew S
Grossberg, George T
Wright, Wendy L
author_sort Chepke, Craig
collection PubMed
description The presence of hallucinations and delusions in patients with neurodegenerative disease correlates negatively with function, cognition, quality of life, and survival. When these patients still have insight, the treatment of mild hallucinations may reduce the risk of progression to more severe symptoms, specifically hallucinations without insight or delusions. On October 22, 2020, a multidisciplinary consensus panel comprising United States-based experts in geriatric psychiatry, geriatric medicine, family medicine, movement disorders, and neuropsychology was convened remotely to discuss best practices for using telemedicine to evaluate, diagnose, and treat psychosis in patients with neurodegenerative diseases. This review reflects the opinions and recommendations discussed at this meeting. Despite drawbacks, telemedicine can offer several advantages over in-person care, particularly for older adults, and may be a unique opportunity for care of patients with neuropsychiatric symptoms. While telemedicine may not be suitable for all patients, it allows the involvement of specialists from multiple geographic locations and the extension of care to homebound individuals. Patients with neurodegenerative diseases who are likely to become homebound as the disease advances may benefit greatly from telemedicine as a standard of care. Healthcare provided via telemedicine should be nothing less than what would be offered to the patient in person. Telemedicine may present some difficulties, including technological issues and inherent constraints of remote care, but with proper planning many problems could be diminished. Technical issues associated with telemedicine are inevitable but may be partially offset by providing clear directions ahead of any tele-visit to ensure connectivity and access to the videoconferencing platform. Alternative procedures to communicate should be established in the eventuality of technological issues. Using these strategies, telemedicine can serve as a valuable complement to traditional in-person practices for the diagnosis and management of hallucinations and delusions associated with Parkinson’s disease psychosis or dementia-related psychosis.
format Online
Article
Text
id pubmed-8711560
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87115602022-01-05 Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease Chepke, Craig Shaughnessy, Lynn W Brunton, Stephen Farmer, Jill G Rosenzweig, Andrew S Grossberg, George T Wright, Wendy L Int J Gen Med Perspectives The presence of hallucinations and delusions in patients with neurodegenerative disease correlates negatively with function, cognition, quality of life, and survival. When these patients still have insight, the treatment of mild hallucinations may reduce the risk of progression to more severe symptoms, specifically hallucinations without insight or delusions. On October 22, 2020, a multidisciplinary consensus panel comprising United States-based experts in geriatric psychiatry, geriatric medicine, family medicine, movement disorders, and neuropsychology was convened remotely to discuss best practices for using telemedicine to evaluate, diagnose, and treat psychosis in patients with neurodegenerative diseases. This review reflects the opinions and recommendations discussed at this meeting. Despite drawbacks, telemedicine can offer several advantages over in-person care, particularly for older adults, and may be a unique opportunity for care of patients with neuropsychiatric symptoms. While telemedicine may not be suitable for all patients, it allows the involvement of specialists from multiple geographic locations and the extension of care to homebound individuals. Patients with neurodegenerative diseases who are likely to become homebound as the disease advances may benefit greatly from telemedicine as a standard of care. Healthcare provided via telemedicine should be nothing less than what would be offered to the patient in person. Telemedicine may present some difficulties, including technological issues and inherent constraints of remote care, but with proper planning many problems could be diminished. Technical issues associated with telemedicine are inevitable but may be partially offset by providing clear directions ahead of any tele-visit to ensure connectivity and access to the videoconferencing platform. Alternative procedures to communicate should be established in the eventuality of technological issues. Using these strategies, telemedicine can serve as a valuable complement to traditional in-person practices for the diagnosis and management of hallucinations and delusions associated with Parkinson’s disease psychosis or dementia-related psychosis. Dove 2021-12-23 /pmc/articles/PMC8711560/ /pubmed/34992442 http://dx.doi.org/10.2147/IJGM.S335739 Text en © 2021 Chepke et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Perspectives
Chepke, Craig
Shaughnessy, Lynn W
Brunton, Stephen
Farmer, Jill G
Rosenzweig, Andrew S
Grossberg, George T
Wright, Wendy L
Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
title Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
title_full Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
title_fullStr Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
title_full_unstemmed Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
title_short Using Telemedicine to Assess and Manage Psychosis Among Outpatients with Neurodegenerative Disease
title_sort using telemedicine to assess and manage psychosis among outpatients with neurodegenerative disease
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711560/
https://www.ncbi.nlm.nih.gov/pubmed/34992442
http://dx.doi.org/10.2147/IJGM.S335739
work_keys_str_mv AT chepkecraig usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease
AT shaughnessylynnw usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease
AT bruntonstephen usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease
AT farmerjillg usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease
AT rosenzweigandrews usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease
AT grossberggeorget usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease
AT wrightwendyl usingtelemedicinetoassessandmanagepsychosisamongoutpatientswithneurodegenerativedisease